AutoTEQ 2.0 (.teq)
AutoTEQ 2.0 is a major upgrade to our tokenization engine, introducing AI-driven automation, a dedicated smart contract system, and an integrated subnet architecture for enhanced autonomy, security, and scalability.
Key Innovations in AutoTEQ 2.0:
- AI-Powered Tokenization & Smart Contract Automation – AI-driven automation analyzes, optimizes, and executes tokenization contracts for real-world and digital assets.
- Dedicated Smart Contract System – Eliminates reliance on external contracts, giving AutoTEQ full control over subdomain issuance, tokenization fees, and asset verification.
- Integrated Subnet for Secure & Scalable Processing – Governing node and subnet architecture ensure faster, more secure transactions.
- Advanced Web3 KYC & Compliance – Leverages on-chain identity verification and decentralized KYC integration.
- Multi-Layered Security & AI Verification – AI-driven fraud detection and real-time document authentication.
- Cross-Industry Integration – Supports real estate, finance, supply chain, and digital identity management.
With its self-sustaining architecture and AI-driven intelligence, AutoTEQ 2.0 is the standard for trustless, scalable asset management in the Web3 era.
MedX (.mdx)
MedX is designed to revolutionize healthcare data management and verification through blockchain technology. Built on the XDC Network, MedX ensures secure, immutable, and verifiable medical records.
Key Features of MedX:
- Decentralized Patient Records – Patients own and manage their medical data securely.
- Instant Verification – Blockchain-based authentication for medical documents, prescriptions, and certifications.
- Secure Data Sharing – Permission-based access for authorized healthcare providers.
- Fraud Prevention – Eliminates tampering and counterfeit medical documents.
- Cross-Border Healthcare – Ensures accessibility of medical records globally.
MedX is built to enhance trust, security, and efficiency in healthcare while ensuring compliance with data privacy regulations like HIPAA and GDPR.
